BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26095193)

  • 1. A Fluorescent Adenosine Analogue as a Substrate for an A-to-I RNA Editing Enzyme.
    Mizrahi RA; Shin D; Sinkeldam RW; Phelps KJ; Fin A; Tantillo DJ; Tor Y; Beal PA
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8713-6. PubMed ID: 26095193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the RNA-editing reaction of ADAR2 with structural and fluorescent analogues of the GluR-B R/G editing site.
    Stephens OM; Yi-Brunozzi HY; Beal PA
    Biochemistry; 2000 Oct; 39(40):12243-51. PubMed ID: 11015203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate analogues for an RNA-editing adenosine deaminase: mechanistic investigation and inhibitor design.
    Véliz EA; Easterwood LM; Beal PA
    J Am Chem Soc; 2003 Sep; 125(36):10867-76. PubMed ID: 12952466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site.
    Jaikaran DC; Collins CH; MacMillan AM
    J Biol Chem; 2002 Oct; 277(40):37624-9. PubMed ID: 12163487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine Deaminases That Act on RNA (ADARs).
    Wang Y; Zheng Y; Beal PA
    Enzymes; 2017; 41():215-268. PubMed ID: 28601223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do ADARs bind RNA? New protein-RNA structures illuminate substrate recognition by the RNA editing ADARs.
    Thomas JM; Beal PA
    Bioessays; 2017 Apr; 39(4):. PubMed ID: 28217931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of duplex RNA by the deaminase domain of the RNA editing enzyme ADAR2.
    Phelps KJ; Tran K; Eifler T; Erickson AI; Fisher AJ; Beal PA
    Nucleic Acids Res; 2015 Jan; 43(2):1123-32. PubMed ID: 25564529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic substrate analogs for the RNA-editing adenosine deaminase ADAR-2.
    Yi-Brunozzi HY; Easterwood LM; Kamilar GM; Beal PA
    Nucleic Acids Res; 1999 Jul; 27(14):2912-7. PubMed ID: 10390533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
    Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
    RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of an RNA editing substrate bearing 2'-deoxy-2'-mercaptoadenosine.
    Jayalath P; Pokharel S; Véliz E; Beal PA
    Nucleosides Nucleotides Nucleic Acids; 2009 Feb; 28(2):78-88. PubMed ID: 19219738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate recognition by ADAR1 and ADAR2.
    Wong SK; Sato S; Lazinski DW
    RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.
    Källman AM; Sahlin M; Ohman M
    Nucleic Acids Res; 2003 Aug; 31(16):4874-81. PubMed ID: 12907730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An I for an A: Dynamic Regulation of Adenosine Deamination-Mediated RNA Editing.
    Vesely C; Jantsch MF
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transition state analogue for an RNA-editing reaction.
    Haudenschild BL; Maydanovych O; Véliz EA; Macbeth MR; Bass BL; Beal PA
    J Am Chem Soc; 2004 Sep; 126(36):11213-9. PubMed ID: 15355102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases.
    Mizrahi RA; Phelps KJ; Ching AY; Beal PA
    Nucleic Acids Res; 2012 Oct; 40(19):9825-35. PubMed ID: 22885375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matching active site and substrate structures for an RNA editing reaction.
    Pokharel S; Jayalath P; Maydanovych O; Goodman RA; Wang SC; Tantillo DJ; Beal PA
    J Am Chem Soc; 2009 Aug; 131(33):11882-91. PubMed ID: 19642681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site.
    Ohman M; Källman AM; Bass BL
    RNA; 2000 May; 6(5):687-97. PubMed ID: 10836790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA.
    Zheng Y; Lorenzo C; Beal PA
    Nucleic Acids Res; 2017 Apr; 45(6):3369-3377. PubMed ID: 28132026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.